Skip to content
Medical Health Aged Care, Seniors Interest

Funding Success to Investigate Brain Microbiome

Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney 2 mins read
Credit: Dreamstime

For the first time, UNSW Sydney’s Centre for Healthy Brain Ageing (CHeBA) will consider the role of the brain microbiome in promoting health and the prevention of cognitive decline and dementia, thanks to a $90,000 grant awarded by the Mostyn Family Foundation – an inter-generational Foundation that was established in 2011 by brothers Richard, Andrew and Robert with their late father Bob Mostyn.

The new research, led by Dr Karen Mather, Head of CHeBA’s Genomics & Epigenomics Group, will enable researchers to systematically investigate the existence of the brain microbiome and its influence on healthy brain ageing.

Dementia has a profound impact on the population, both at an individual and societal level. There are more than 57 million people worldwide living with dementia and currently over 420,000 Australians with a dementia diagnosis. Despite increasing evidence that certain environmental and lifestyle factors can help reduce risk of dementia, there is limited understanding of the microbiome of the brain and its relationship with neurodegenerative diseases such as Alzheimer’s.

“The significance of the human microbiome in health and disease has never been more evident,” says Dr Mather.

“Up until now research has focused solely on the role of the gut microbiome in maintaining health and fighting disease.”

The microbiome includes bacteria and viruses, which reside within and outside our bodies. These organisms impact our physiology in diverse ways, including influencing the regulation of our immune system, digestion and metabolism. The microbiome plays essential roles in healthy individuals but can also contribute to disease.

More recently research has been directed toward exploring the presence or absence of a brain microbiome, which is known to have implications for brain health and disease. However, this is a contentious issue with previous work yielding inconsistent results.

“This project will investigate the existence of the brain microbiome by optimising brain sampling and microbiome techniques and examining brains from ‘healthy’ and neurodegenerative disease cases obtained from the Sydney Brain Bank at Neuroscience Research Australia,” says Dr Mather.

“Significantly, this work will add to the body of literature regarding the brain microbiome, and its potential relationships with healthy brain ageing and neurodegenerative disease.”

Co-Director of CHeBA, Professor Perminder Sachdev says that this project has the potential to break new ground and produce a paradigm shift in our conceptualisation of neurodegenerative disease.

 

 The study is led by Head of CHeBA’s Genomics & Epigenomics Group, Dr Karen Mather, working together with Dr Claire Shepherd, Director of the Sydney Brain Bank, based at Neuroscience Research Australia (NeuRA), and Dr Fatima El-Assaad, an international expert on the microbiome from the Microbiome Research Centre at UNSW. An international PhD student will also work on this project using cutting-edge techniques to examine the brain microbiome.


About us:

www.cheba.unsw.edu.au


Contact details:

Heidi Douglass | 0435 579 202

h.douglass@unsw.edu.au

Media

More from this category

  • Medical Health Aged Care
  • 20/04/2024
  • 04:30
Dementia Australia

Join us TODAY for Bendigo Memory Walk & Jog

What: Dementia Australia’sBendigoMemory Walk & Jog When: Saturday 20 April, from 8am Who: More than 390 locals participating on the day. People who have been impacted by dementia, their family, friends and carers. Where: Bendigo Botanic Gardens, Bendigo For more information visit: www.memorywalk.com.au Walk or jog with us. We are in this together. Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people…

  • Contains:
  • Medical Health Aged Care, Science
  • 19/04/2024
  • 15:00
Monash University

Large-scale genetic study finds new link between Irritable Bowel Syndrome and the cardiovascular system

New research published today in the journal Cellular and Molecular Gastroenterology and Hepatology sheds light on disease mechanisms common to irritable bowel syndrome (IBS) and cardiovascular diseases (CVD). Led by Dr Leticia Camargo Tavares, a Postdoctoral Fellow at the Hypertension Research Laboratory within Monash University’s School of Biological Sciences, the study reveals novel insights into the genetic underpinnings of IBS, offering potential avenues for therapeutic intervention. IBS is one of the most prevalent gastrointestinal disorders globally, affecting up to 10 per cent of the population, with a disproportionate impact on women. It is characterised by a complex range of symptoms…

  • Medical Health Aged Care
  • 19/04/2024
  • 11:13
Gilead Sciences Australia

Australian community organisations addressing viral hepatitis receive AU$400,000 via global Gilead ALL4LIVER Grant program

– Gilead Sciences joins forces with World Hepatitis Alliance and experts to drive progress on viral hepatitis elimination targets – – Australian initiatives well represented in Gilead’s US$4 million global fund to empower local communities in the fight against viral hepatitis – Melbourne, Australia, 19 April 2024 – Today, on World Liver Day, Gilead Sciences Australia has announced nine local community organisations addressing viral hepatitis will receive a combined AU$400,000 via the global Gilead ALL4LIVER Grant. The recipients were selected by an independent external review panel of global experts, including the World Hepatitis Alliance. Australia has committed to achieving the…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.